Product Name: EPLIN antibody
Applications: ICC/IF, WB
Predicted Target Size: 85 kDa (note) (5)
Positive Controls: HeLa , HepG2
Form Supplied: Liquid
Concentration: 0.88 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: LIM domain and actin binding 1
Background: EPLIN is a cytoskeleton-associated protein that inhibits actin filament depolymerization and cross-links filaments in bundles (Maul et al., 2003 [PubMed 12566430]).[supplied by OMIM]
Synonyms: EPLIN antibody, FLJ38853 antibody, MGC131726 antibody, SREBP3 antibody, LIMA1 antibody, 1110021C24Rik antibody, sterol regulatory element binding protein 3 antibody, epithelial protein lost in neoplasm beta antibody, LIM domain and actin-binding protein 1 antibody, LIM domain and actin binding 1 antibody
Cellular Localization: Cytoplasm , Cell junction , focal adhesion , cytoskeleton
CAS NO: 1421373-66-1
Product: Canertinib (dihydrochloride)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the C-terminus region of human EPLIN. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/20575640?dopt=Abstract
